Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study

BMC Endocrine Disorders

Volumn 12, Issue , 2012, Pages

  Sigurjonsdottir, Helga A ^a   Gronowitz, Mikael ^b   Andersson, Ove ^a   Eggertsen, Robert ^c   Herlitz, Hans ^a   Sakinis, Augustinas ^a   Wangberg, Bo ^a   Johannsson, Gudmundur ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Nödinge Primary Health Care Center   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adrenal hyperplasia; Aldosterone; Endocrine hypertension; Hyperaldosteronism; Hypertension; Renin; Resistant hypertension

Indexed keywords

ALDOSTERONE; ANTIHYPERTENSIVE AGENT; SPIRONOLACTONE;

ADENOMA; ADRENAL HYPERPLASIA; ADRENALECTOMY; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PROSPECTIVE STUDY; SALT LOADING;

EID: 84865817639     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-12-17     Document Type: Article

References (48)

1. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005, 45(8):1243-1248. 10.1016/j.jacc.2005.01.015, 15837256.
2. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000, 85(8):2854-2859. 10.1210/jc.85.8.2854, 10946893.
3. Nishizaka MK, Pratt-Ubunama M, Zaman MA, Cofield S, Calhoun DA. Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension. Am J Hypertens 2005, 18(6):805-812. 10.1016/j.amjhyper.2005.01.002, 15925740.
4. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, et al. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000, 85(5):1863-1867. 10.1210/jc.85.5.1863, 10843166.
5. Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005, 51(2):386-394. 10.1373/clinchem.2004.041780, 15681560.
6. Grim CE, Cowley AW, Hamet P, Gaudet D, Kaldunski ML, Kotchen JM, Krishnaswami S, Pausova Z, Roman R, Trembley J, et al. Hyperaldosteronism and Hypertension. Ethnic differences. Hypertension 2005, 45:766-772. 10.1161/01.HYP.0000154364.00763.d5, 15699471.
7. Williams JS, Williams GH, Raji A, Jeunemaitre X, Brown NJ, Hopkins PN. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens 2006, 20:129-136. 10.1038/sj.jhh.1001948, 16292348.
8. Unger N, Lopez Schmidt I, Pitt C, Walz MK, Philipp T, Mann K, Petersenn S. Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass. Eur J Endocrinol 2004, 150:517-523. 10.1530/eje.0.1500517, 15080782.
9. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21(4):315-318. 10.1111/j.1440-1681.1994.tb02519.x, 7923898.
10. Kumar A, Lall SB, Ammini A, Peshin SS, Karmarkar MG, Talwar KK, Seth SD. Screening of a population of young hypertensives for primary hyperaldosteronism. J Hum Hypertens 1994, 8(9):731-732.
11. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM. High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000, 14.
12. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF. Increased diagnosis of primary aldosteronism, including surgically correctabel forms, in centers from five continents. J Clin Endocrinol Metab 2004, 89(3):1045-1050. 10.1210/jc.2003-031337, 15001583.
13. Seiler L, Rump LC, Schulte-Mönting J, Slawik M, Borm K, Pavenstädt H, Beuschlein F, Reincke M. Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. Eur J Endocrinol 2004, 150:329-337. 10.1530/eje.0.1500329, 15012618.
14. Strauch B, Zelinka T, Hampf M, Bernhardt R, Widimsky J. Prevalence of primary hyperaldoteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003, 17:349-352. 10.1038/sj.jhh.1001554, 12756408.
15. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006, 48(11):2293-2300. 10.1016/j.jacc.2006.07.059, 17161262.
16. Shigematsu K, Yamaguchi N, Nakagaki T, Sakai H. A case of unilateral adrenal hyperplasia being difficult to distinguish from aldosterone-producing adenoma. Exp Clin Endocrinol Diabetes 2008, 117(3):124-128.
17. Morioka M, Kobayashi T, Sone A, Furukawa Y, Tanaka H. Primary aldosteronism due to unilateral adrenal hyperplasia: report of two cases and review of the literature. Endocr J 2000, 47(4):443-449. 10.1507/endocrj.47.443, 11075725.
18. Tan Y, Ogilvie J, Triponez F, Caron N, Kebebew E, Clark O, Duh Q. Selective use of adrenal venous sampling in the lateralization of aldosterone-producing adenomas. World J Surg 2006, 30(5):879-885. 10.1007/s00268-005-0622-8, 16680603.
19. Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T. Unique cases of unilateral hyperaldosteronemia due to multiple adrenocortical micronodules, which can only be detected by selective adrenal venous sampling. Metabolism 2002, 51(3):350-355. 10.1053/meta.2002.30498, 11887172.
20. Mathur A, Kemp C, Dutta U, Baid S, Ayla A, Chang R, Steinberg S, Papademetriou V, Lange E, Libutti S, et al. Consequences of Adrenal Venous Sampling in Primary Hyperaldosteronism and Predictors of Unilateral Adrenal Disease. J Am Coll Surg 2010, 211(3):384-390. 10.1016/j.jamcollsurg.2010.05.006, 2930893, 20800196.
21. Bravo EL, Tarazi RC, Dustan HP, Fouad FM, Textor SC, Gifford RW, Vidt DG. The changing clinical spectrum of primary aldosteronism. Am J Med 1983, 74(4):641-651. 10.1016/0002-9343(83)91022-7, 6340491.
22. Vallotton MB. Primary aldosteronism. Part I diagnosis of primary hyperaldosteronism. Clin Endocrinol 1996, 45:47-52.
23. Arteaga E, Klein R, Biglieri EG. Use of the saline infusion test to diagnose the cause of primary aldosteronism. Am J Med 1985, 79:722-728. 10.1016/0002-9343(85)90523-6, 3907346.
24. Mulatero P, Milan A, Fallo F, Regolisti G, Pizzolo F, Fardella CE, Mosso L, Marafetti L, Veglio F, Maccario M. Comparison of confirmatory tests for the diagnosis of primary aldosteronism. J Clin Endocr Metab 2006, 91(7):2618-2623. 10.1210/jc.2006-0078, 16670162.
25. Dunnick NR, Doppman JL, Mills SR, Gill JR. Preoperative diagnosis and localization of aldosteronomas by measurement of corticosteroids in adrenal venous blood. Radiology 1979, 133:331-333.
26. Young WF, Stanson AW, Grant CS, Thompson GB, van Heerden JA. Primary aldosteronism: adrenal venous sampling. Surgery 1996, 120:913-920. 10.1016/S0039-6060(96)80033-X, 8957473.
27. Doppman JL. Hyperaldosteronism: sampling the adrenal veins. Radiology 1996, 198:309-312.
28. Doppman JL, Gill JRJ, Miller DL, Chang R, Gupta R, Friedman TC, Choyke PL, Feuerstein IM, Dwyer AJ, Jicha DL. Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology 1992, 184(3):677-682.
29. Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984, 8:163-169. 10.1097/00000478-198403000-00001, 6703192.
30. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982, 6(7):655-663. 10.1097/00000478-198210000-00007, 7180965.
31. Letavernier E, Peyrard S, Amar L, Zinzindohoué F, Fiquet B, Plouin P-F. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 2008, 26(9):1816-1823. 10.1097/HJH.0b013e3283060f0c, 18698217.
32. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007, 66(5):607-618.
33. Funder JW, Carey RM, Fardella CE, Gomez-Sanchez C, Mantero F, Stowasser M, Young WF, Montori VM. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008, 93:3266-3281. 10.1210/jc.2008-0104, 18552288.
34. Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 2002, 89:1587-1593. 10.1046/j.1365-2168.2002.02261.x, 12445071.
35. Lin YH, Lee HH, Liu KL, Shih SR, Chueh SC, Lin WC, Lin LC, Lin LY, Chung SD, Wu VC, et al. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy. Surgery 2011, 150(3):526-533. 10.1016/j.surg.2011.02.006, 21514614.
36. Sukor N, Kogovsek C, Gordon RD, Robson D, Stowasser M. Improved quality of life, blood pressure, and biochemical status following laparoscopic adrenalectomy for unilateral primary aldosteronism. J Clin Endocr Metab 2010, 95(3):1360-1364. 10.1210/jc.2009-1763, 20089615.
37. Rossito G, Toniato A, Rossi GP. Adrenal venous sampling but not computed tomography is essential before undertaking adrenalectomy for primary aldosteronism. Surgery 2010, 149(6):852.
38. Amar L, Plouin PE, Steichen O. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis 2010, 19:5-9.
39. Mattsson C, Young W. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2006, 2(4):198-208.
40. Nagata D, Takahashi M, Sawai K, Tagami T, Usui T, Shimatsu A, Hirata Y, Naruse M. Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension 2006, 48(1):165-171. 10.1161/01.HYP.0000226054.53527.bb, 16754797.
41. Hashikabe Y, Suzuki K, Jojima T, Uchida K, Hattori Y. Aldosterone impairs vascular endothelial cell function. J Cardiovasc Pharmacol 2006, 47:609-613. 10.1097/01.fjc.0000211738.63207.c3, 16680076.
42. Oberleithner H. Aldosterone makes human endothelium stiff and vulnerable. Kidney Int 2005, 67(5):1680-1682. 10.1111/j.1523-1755.2005.00263.x, 15840012.
43. Rizzoni D, Paiardi S, Rodella L, Porteri E, De Ciuceis C, Rezzani R, Boari G, Zani F, Miclini M, Tiberio G, et al. Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. J Clin Endocr Metab 2006, 91(7):2638-2642. 10.1210/jc.2006-0101, 16608890.
44. Campbell SE, Diaz-Arias AA, Weber KT. Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Press 1992, 1:149-156. 10.3109/08037059209077510, 1345047.
45. Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello M-J, et al. Renal damage in primary aldosteronism. Hypertension 2006, 48:232-238. 10.1161/01.HYP.0000230444.01215.6a, 16801482.
46. Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocr Metab 2005, 90:5070-5076. 10.1210/jc.2005-0681, 15941863.
47. Milliez P, Giererd X, Plouin PE, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascualr events in patients with primary aldosteronism. J Am Coll Cardiol 2005, 45:1243-1248. 10.1016/j.jacc.2005.01.015, 15837256.
48. Fujiwara M, Murao K, Imachi H, Yoshida K, Muraoka T, Ohyama T, Kushida Y, Haba R, Kakehi Y, Ishida T. Misdiagnosis of two cases of primary aldosteronism owing to failure of computed tomography to detect adrenal microadenoma. Am J Med Sci 2010, 340(4):335-337. 10.1097/MAJ.0b013e3181e95587, 20881759.